Clicky

Sunday, November 8, 2026

Breaking News

Latest SEC filings as they come in

Torray Investment Partners reports $757.8M in holdings

Torray Investment Partners LLC files 13F-HR, revealing $757.8 million in holdings as of September 30, 2026, with notable investments in major companies.

UBS AG launches $100,000 Trigger Autocallable Notes

UBS AG has filed for $100,000 Trigger Autocallable Contingent Yield Notes linked to Broadcom Inc., emphasizing its market strategy in National Commercial Banks.

Sagard Private Income Fund files fidelity bond under SEC rules

Sagard Private Income Fund Inc. files a fidelity bond under SEC regulations, highlighting the importance of insurance in the investment industry.

Graf Global Corp. Advances Merger with BIG3 HoldCo LLC

Graf Global Corp. is progressing with its merger with BIG3 HoldCo LLC, aiming to transform sports investment through public engagement.

Betvisors, Inc. Completes $150,000 Private Offering

Betvisors, Inc. has successfully raised $150,000 through a private offering to support its growth and reimburse expenses.

Ark7 Properties Advance LLC Secures Qualification for Offering

Ark7 Properties Advance LLC has secured qualification for its offering, enabling it to attract investments and advance its business strategy in the real estate sector.

FT 13337 Receives Effectiveness for S-6 Filing

FT 13337 has received effectiveness for its S-6 filing, signaling confidence in its investment offerings and impacting stakeholders in the investment sector.

Bitari Inc S-1 Registration Becomes Effective for Capital Raise

Bitari Inc's S-1 registration has been declared effective, allowing the company to proceed with its capital-raising efforts in the commodity contracts industry.

Cabbacis Inc files qualification statement for offerings

Cabbacis Inc has filed a qualification statement, indicating readiness for new offerings in the tobacco products sector.

DevvStream Legacy Corp. confirms filing effectiveness with SEC

DevvStream Legacy Corp. files an effectiveness notice with the SEC, marking a significant step in its investment strategy.

Aspen Neuroscience receives effectiveness for S-1 registration

Aspen Neuroscience, Inc. secures effectiveness for its S-1 registration statement, marking a significant step toward a potential public offering.

OPAY Ltd's F-1 Registration Statement Receives Effectiveness

OPAY Ltd's F-1 registration statement has been declared effective, paving the way for its public offering and impacting the depository banking sector.

Nocopi Technologies Inc. Receives Effectiveness for S-1

Nocopi Technologies Inc. has received effectiveness for its S-1 registration, paving the way for potential capital raising and growth opportunities.

BioAtla Receives Effectiveness for S-1 Registration Statement

BioAtla, Inc. has received effectiveness for its S-1 registration statement, paving the way for future offerings in the biological products sector.

DevvStream Legacy Corp. Announces Corporate Name Change

DevvStream Legacy Corp. updates its corporate name, signaling a strategic shift in the Investors, NEC sector. The change reflects ongoing evolution.

OPay Ltd secures effective registration for ADRs

OPay Ltd has received effective registration for its American Depositary Receipts, enhancing its U.S. market presence and impacting the financial services industry.

Bambusa Therapeutics receives SEC effectiveness for S-1

Bambusa Therapeutics, Inc. has received SEC effectiveness for its S-1 registration statement, paving the way for its capital-raising efforts.

Brightline Interactive gains SEC approval for S-3 registration

Brightline Interactive, Inc. receives SEC approval for its S-3 registration statement, enhancing its ability to raise capital in the computer programming services sector.

RedCloud Holdings files effectiveness notice for securities

RedCloud Holdings plc files an effectiveness notice, allowing it to proceed with its capital-raising efforts in the retail sector.

First Tracks Biotherapeutics Receives SEC Approval for S-1

First Tracks Biotherapeutics has secured SEC approval for its S-1 registration statement, paving the way for its public offering.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →